Stay updated on Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating a recent update in the context of medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-22T07:37:34.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    19 days ago
    Change Detected
    Summary
    The value 03 20 has been updated to 05 07 on the webpage, indicating a recent change in the study record details related to a research study on a new weekly insulin, Insulin Icodec, in patients with Type 2 Diabetes, sponsored by Novo Nordisk A/S.
    Difference
    0.6%
    Check dated 2024-05-07T19:59:02.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:33:26.000Z thumbnail image

Stay in the know with updates to Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Weekly Insulin Icodec with Semaglutide in Type 2 Diabetes Clinical Trial page.